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Abstract  Photorefractive  keratectomy  (PRK)  remodels  corneal  stroma  to  compensate  refrac-
tive errors.  The  removal  of  epithelium  and  the  ablation  of  stroma  provoke  the  disruption  of
corneal nerves  and  a  release  of  several  peptides  from  tears,  epithelium,  stroma  and  nerves.  A
myriad of  cytokines,  growth  factors,  and  matrix  metalloproteases  participate  in  the  process  of
corneal wound  healing.  Their  balance  will  determine  if  reepithelization  and  stromal  remodeling
are appropriate.  The  ﬁnal  aim  is  to  achieve  corneal  transparency  for  restoring  corneal  function,
and a  proper  visual  quality.  Therefore,  wound-healing  response  is  critical  for  a  successful  refrac-
tive surgery.  Our  goal  is  to  provide  an  overview  into  how  corneal  wounding  develops  following
PRK. We  will  also  review  the  inﬂuence  of  intraoperative  application  of  mitomycin  C,  bandage
contact  lenses,  anti-inﬂammatory  and  other  drugs  in  preventing  corneal  haze  and  post-PRK
pain.
© 2014  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
PALABRAS  CLAVE
Queratectomía
Regeneración  de  la  córnea  tras  queratectomía  fotorreactiva:  revisión  bibliográﬁcafotorrefractiva; Resumen  La  queratectomía  fotorrefractiva  (PRK)  remodela  el  estroma  de  la  córnea  para  com-
pensar los  errores  refractivos.  La  eliminación  del  epitelio  y  la  ablación  del  estroma  provoca  laCórnea;
Curación  de  heridas;
Lentes  de  contacto
alteración de  los  nervios  corneales  y  la  liberación  de  diversos  péptidos  de  la  lágrima,  epite-
lio, estroma  y  nervios.  Innumerables  citoquinas,  factores  de  crecimiento  y  metaloproteasas
de la  matriz  participan  en  el  proceso  de  regeneración  y  cicatrización  corneal.  Su  equilibrio
determinará  si  la  re-epitelización  y  la  remodelación  del  estroma  son  adecuados.  El  objetivo  ﬁnal The authors have not proprietary or commercial interest in the medical devices that are involved in this manuscript.
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es  el  logro  de  la  transparencia  corneal  para  restablecer  la  función  de  la  córnea,  así  como  la
calidad visual  adecuada.  Por  tanto,  la  respuesta  de  regeneración  y  cicatrización  corneal  es
esencial para  el  éxito  de  la  cirugía  refractiva.  Nuestro  objetivo  es  aportar  una  visión  general
sobre el  modo  en  que  se  desarrolla  dicho  proceso  tras  la  PRK.  Revisaremos  también  la  inﬂuencia
de la  aplicación  intraoperatoria  de  mitomicina  C,  lentes  de  contacto  terapéuticas,  y  otros
fármacos  para  prevenir  el  haze  y  el  dolor  tras  la  PRK.
© 2014  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los
derechos reservados.
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dThe  ablation  surgery  of  the  corneal  surface  for  the  cor-
ection  of  refractive  errors  began  with  the  development
f  the  excimer  laser.  The  acronym  laser  means  ‘‘Light
mpliﬁcation  by  the  Stimulated  Emission  of  Radiation’’.
hotorefractive  keratectomy  (PRK),  developed  by  Trokel
nd  colleagues  in  1983,  uses  an  excimer  laser  that  emits
ltraviolet  light  of  193  nanometers  (nm),  a  combination  of
rgon  and  Fluor  (ArF)  to  remodel  the  corneal.1--6 It  was  not
ntil  1996  when  the  Food  and  Drug  Administration  (FDA)
proved  PRK  as  a  refractive  surgery  technique.7 In  PRK  the
xcimer  laser  acts  on  the  anterior  corneal  stroma,2,8,9 pro-
ucing  a  stromal  remodeling,  and,  consequently,  inducing  a
hange  in  corneal  refraction.10,11 It  corrects  mild  to  mod-
rate  myopia,  hyperopia  and  astigmatism,  with  high  level
f  safety  and  efﬁcacy.3,11--20 However,  the  use  of  PRK  has
een  reduced  over  the  past  years  by  the  introduction  of  the
aser  In  Situ  Keratomileusis  (LASIK).12,21 Although  LASIK  pro-
ides  less  postoperative  pain,  less  inﬂammation,  and  faster
orneal  wound  healing  and  visual  recovery,8,17,19,22--25 PRK
ay  be  a  useful  alternative  in  post-radial  keratotomy,26--28
ost-penetrating  keratoplasty,29 in  thin  corneas,  irregular
opographies,  alterations  of  the  basal  membrane,  treatment
f  some  LASIK  ﬂap  complications  or  residual  refractive  errors
fter  LASIK.11,12,19,30--32 It  is  also  indicated  in  military  pilots,
rofessional  athletes,  or  patients  that  have  a  high  risk  for
raumatic  postoperative  ﬂap  dislocation.12,31 In  addition  to
he  above-mentioned  advantages,  the  PRK  has  gained  pop-
larity  with  the  recent  wave  front  guided  laser  ablation,
hich  reduces  postoperative  high  order  aberrations  (HOA),
mproving  the  optical  quality.30
The  visual  quality  might  not  be  optimal  if  some
omplications  take  place,  like  subepithelial  corneal  haze,
pithelial  hypertrophy,  regression  of  refractive  error,  depo-
ition  of  subepithelial  extracellular  matrix  or  ﬁbrosis.
ther  adverse  effects  include  postoperative  pain,  abnormal
orneal  nerve  regeneration,  and  night  vision  symptoms  like
alos  and  glare.3,10,11,14,18,22,33--40
The  purpose  of  this  review  is  to  explain  the  main  cellular
hanges  and  complications  that  occur  in  different  corneal
ayers  after  PRK,  and  to  explain  how  they  affect  the  visual
uality.  We  discuss  the  role  of  mytomicin  C  and  bandage
ontact  lenses  in  corneal  regeneration,  and  the  role  of  dif-
erent  drugs  in  postoperative  corneal  pain  management.
orneal Wound Healingorneal  wound  healing  is  a  complex  process  that,  in  nor-
al  conditions,  culminates  in  the  restoration  of  the  tissue,
ithout  scar  formation  or  vascularization.  The  aim  is  to
e
t
o
Paintain  transparency  to  recover  a  proper  visual  function.
fter  epithelial  injury,  the  corneal  healing  starts  with  the
emoval  of  necrotic  cells.41 Fibronectin  provides  a  tran-
ient  matrix  for  the  adhesion  of  migrating  cells,  until  an
pithelial  monolayer  covers  the  injured  area.42 Fibronectin
lso  stimulates  the  production  of  plasminogen  activator
PAA),  and  by  a  cascade  of  events,  cell-subepithelial  matrix
dhesions  break  down.42 In  the  next  step,  limbal  stem
ells  undergo  mitosis  to  reestablish  lost  cells,  and  with  the
nchoring  of  hemidesmosomes  to  the  underlying  stroma,  the
pithelial  regeneration  process  completes.41 Stromal  wound
ealing  depends  on  epithelial  cells,  and  on  their  interac-
ion  with  keratocytes.43 Following  stromal  injury,  released
ytokines  induce  the  apoptosis  of  keratocytes  under  the
ound,  and  stimulate  the  proliferation  and  migration  of
eighboring  keratocytes.44 These  active  keratocytes  synthe-
ize  matrix  metalloproteases  (MMP)  to  remodel  the  stroma.
t  later  stages,  a  number  of  them  take  the  repair  pheno-
ype,  the  so-called  myoﬁbroblasts,45 and  produce  collagen
nd  extracellular  matrix  (ECM),  until  the  basement  mem-
rane  prevents  the  inﬂow  of  cytokines  in  the  stroma,  and
yoﬁbroblast,  presumably,  commit  apoptosis  (Fig.  1).46,47
pithelial  Wound  Healing  Following  PRK
he  corneal  epithelium  is  formed  by  superﬁcial,  wing  and
asal  cells.48,49 In  order  to  facilitate  the  stromal  ablation
n  PRK,  the  corneal  epithelium  is  removed.  The  absence
f  the  epithelium  will  condition  corneal  repair.  Corneal
pithelial  cells  are  the  ﬁrst  cells  involved  in  the  corneal
egeneration  process  after  PRK.50 Epithelial  cells  prolifer-
te  and  migrate  from  the  limbus  and  the  basal  epithelial
ayer  to  reestablish  corneal  layers.8,51 Corneal  regeneration
fter  PRK  can  be  better  understood  using  current,  non-
nvasive,  confocal  microscopy.  It  has  been  used  on  animals
nd  on  humans  for  corneal  cellular  structure  visualization
n  real  time.2,5,10,22,25,40,48 Esquenazi  et  al.22 proved  using  a
ew  generation  high-resolution  in  vivo  confocal  microscope
hat  environmental  conditions  inﬂuenced  the  regeneration
f  the  corneal  epithelium.  They  showed  that  the  number
f  the  superﬁcial  cells  was  reduced  in  desiccating  environ-
ents  compared  with  normal  conditions,  and  the  number  of
asal  epithelial  cells  was  increased.  Histological  studies  con-
ucted  in  animals  and  in  humans,  have  found  that  corneal
pithelium  is  thicker  after  PRK,2,52 caused  by  an  elonga-
ion  of  the  basal  epithelial  cells  and  an  increased  number
f  superﬁcial  cell  layers.25 The  corneal  ﬂattening  in  myopic
RK  may  result  in  postoperative  epithelial  thickening  due  to
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uFigure  1  Corneal  alterations  and  ﬁ
the  lack  of  mechanical  inﬂuences  of  the  upper  eyelid  that
polishes  the  corneal  surface  with  blinking.2 Epithelial  hyper-
plasia  in  PRK  is  associated  with  deep  stromal  ablation  depths
and  with  small  ablation  zones  (4.00--4.5  mm)  because  there
is  a  marked  curvature  change  in  the  edges  of  the  ablated
area.  When  ablation  zones  are  large  (6.00  mm),  they  have
less  demarcated  contours,  and  thus,  the  change  in  epithe-
lial  thickness  is  minimal.53--56 Table  1  shows  the  variation
of  central  corneal  thickness  with  different  surgery  tech-
niques  published  in  the  scientiﬁc  literature.  Erie2 proved
that,  after  PRK,  the  central  epithelial  thickness  returned
to  preoperative  levels  at  1  month.  However,  it  continued
to  progressively  increase  during  the  ﬁrst  year,  being  21%
thicker  at  that  time.  This  result  is  similar  to  the  22%  thick-
ness  increase  seen  in  LASIK  by  Erie  et  al.57 However,  the
time  required  for  thickness  stabilization  differs  between  the
two  techniques,  due  to  the  complex  interaction  of  epithe-
lial  cells  and  activated  keratocytes  in  PRK.2 According  to
Patel  et  al.,25 central  corneal  epithelium  in  LASIK  increased
24%  during  the  ﬁrst  year  after  surgery  and  remained  stable
during  the  next  7  years.  In  PRK,  corneal  thickness  contin-
ued  to  increase  at  1  month,  1  year  and  7  years  (442±39  m,
464±44  m,  471±45  m;  respectively).25 Recently,  Ivarsen
et  al.52 have  concluded  that  in  PRK  and  LASIK,  the  epithelial
thickness  increases  15%--20%  after  surgery,  but  the  epithe-
lial  changes  in  LASIK  occur  during  the  ﬁrst  week  and  remain
unaltered  during  the  following  3  years.  It  has  been  suggested
that  epithelial  hyperplasia  can  induce  a  reduction  of  post-
operative  refractive  effect.  Erie  showed  myopic  regression
signiﬁcantly  associated  with  epithelial  thickness  increase.2
Nevertheless,  Ivarsen  et  al.52 did  not  found  any  correla-
tion  between  changes  in  epithelial  thickness  and  changes
in  refraction  after  PRK  or  LASIK,  probably  because  of  the
small  size  of  their  sample.
Stromal  Wound  Healing  Following  PRKStroma  occupies  approximately  the  90%  of  corneal
thickness,58 and  it  can  be  subdivided  into  three  continuous
layers:  anterior,  middle  and  posterior.49 The  corneal  stroma
is  built  up  from  collagen  ﬁbers,  ground  substance,  kera-
c
d
b
meps  of  wound  healing  following  PRK.
ocytes  and  nerve  ﬁbers.5,49 Keratocytes  --  corneal  stromal
ells  -- play  a  major  role  in  maintaining  corneal  transparency,
nd  synthesizing  the  components  of  the  extracellular  matrix
ECM).58 Active  keratocytes  produce  collagen  and  proteo-
lycans  to  form  the  ECM  after  stromal  injury.  The  human
tromal  cornea  contains  collagen  type  I,  V  and  VI.59,60 Type
 is  predominant  (75%),  followed  by  type  VI  (approximately,
7%).60 Type  III  collagen  appears  in  inﬂammatory  events  or
uring  wound  healing.  Proteoglycans  participate  in  collagen
brillogenesis  and  matrix  assembly.61 After  corneal  injury,
ewly  produced  collagen  ﬁbers  tend  to  have  larger  diam-
ters,  as  they  contain  high  levels  of  dermatan  sulphate  (a
ype  of  proteoglycan)  that  lasts  up  to  6  months.62
Stromal  keratocytes  are  normally  quiescent  or  inactive,
nd  are  the  second  cells  involved  in  the  process  of  corneal
egeneration,  just  after  corneal  epithelial  cells.  After  PRK,
eratocytes  underlying  the  wound  disappear  by  apoptosis
ue  to  a stress  exposure.2,24,37,40,50,63 During  the  ﬁrst  24  h
fter  injury,  macrophages,  monocytes,  T  cells  and  polymor-
honuclear  cells  inﬁltrate  the  area  and  remove  damaged
ells.44,64 Metallonoproteinases  (MMPs)  and  the  plasmino-
en  activator  system  remove  the  affected  extracellular
atrix.9,65--67 The  MMPs  are  proteolytic  enzymes  secreted
y  active  keratocytes  or  ﬁbroblasts,  and  degrade  complex
olecules  of  the  extracellular  matrix.  Although  nine  types
f  MMPs  exist,  in  the  cornea  only  four  MMPs  are  important,
eing  MMP-1  the  most  relevant.67 MMP-8  concentration  has
een  observed  to  be  signiﬁcantly  elevated  in  the  second
ay  after  PRK  (P=.001).68 The  remaining  keratocytes,  adja-
ent  to  wound  borders,  are  activated  in  response  to  various
ytokines  released  by  cells  in  upper  layers,  such  as  inter-
eukin  (IL)-1,  and  growth  factors  like  tumor  necrosis  factor
TNF),  ﬁbroblast  growth  factor  (FGF),  platelet-derived
rowth  factor  (PDGF),  epithelial  growth  factor  (EGF),  and
ransforming  growth  factor  (TGF).2,8,14,22,24,35,51,58,69--74 These
rowth  factors  are  normal  components  of  the  tear  and
orneal  cells,  produced  by  the  lacrimal  gland,35 and  reg-
late  a  variety  of  processes  involved  in  homeostasis  and
orneal  wound  healing,  including  migration,  mitosis  and  cell
ifferentiation.75 Particularly,  transformation  growth  factor
eta  (TGF-beta)  seems  to  transform  active  keratocytes  into
yoﬁbroblasts  that  appear  at  later  stages  of  stromal  heal-
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ng.  Myoﬁbroblasts  can  be  identiﬁed  through  the  expression
f  -smooth  muscle  actin  (SMA).45
PRK  produces  oxygen  free  radicals,  secondary  to  the
xposure  of  ultraviolet  radiation,  thermal  increase,  and
olymorphonuclear  cell  inﬁltration.76,77 Free  oxygen  radi-
als  may  interact  with  lipid  components,  nucleotic  acids,
nd  sulphur  contained  in  enzymes,72,78 and  particularly
ith  reactive  oxygen  species  (ROE)  that  are  considered
o  produce  the  most  reactive  and  cytotoxic  damage.  In
act,  they  have  been  described  as  a  partial  cause  of  ker-
tocyte  apoptosis.77 Among  the  antioxidant  enzymes  that
rotect  the  cornea  from  radicals,  superoxide  dismutase
SOD),  glutathione  peroxidase  (Gpx)  and  catalase  are  the
ost  relevants.75,78 Ascorbic  acid  and  dl-alpha-tocopherol
Vitamin  E)  also  prevents  from  the  effects  of  free  radicals.78
orneal  epithelial  ascorbic  acid  absorbs  ultraviolet  radia-
ion,  protecting  keratocytes,  but  high  or  altered  corneal
scorbate  levels  in  the  human  cornea  after  PRK,  may  pro-
uce  accelerated  keratocyte  death.5 In  rabbit  corneas,
ecreased  activity  of  SOD  and  Gpx  enzymes  has  been  proved
fter  refractive  surgery.78 For  this  reason,  additional  antiox-
dant  enzymes  seem  to  be  involved  in  reducing  corneal
xidative  stress  following  PRK.  1-cys  peroxiredoxin  (1-cys
rx)  may  be  an  important  enzyme  involved  in  the  differentia-
ion,  migration  and  proliferation  of  epithelial  cells.  1-cysPrx
ncreases  4  h  after  PRK  and  remains  in  high  levels  until  7  days
fter  PRK.75
The  density  of  keratocytes  varies  across  the  stroma.  It  is
stimated  that  in  the  anterior  stroma  the  density  is  5%--10%
reater  than  in  middle  and  posterior  stroma.79,80 It  has  been
ocumented  that  a  corneal  stroma  rich  in  keratocytes  pre-
ents  the  epithelial  corneal  infection  or,  at  least,  minimizes
he  extension  of  the  infection.2,5,10 After  PRK,  the  anterior
eratocyte  population  drastically  diminishes,  and  the  distri-
ution  and  shape  is  greatly  altered.2,10,34,40,81,82 In  confocal
icroscopy,  high  reﬂectance,  hyperplasticity,  hypertrophy
nd  a  decrease  in  the  contrast  of  the  anterior  stromal  ker-
tocytes  can  be  observed.34,63,83 Human  histological  studies
onﬁrm  that  the  decrease  of  anterior  stromal  keratocytes  in
umans  and  animal  respond  similarly.84,85 Table  2  shows  the
ariation  of  anterior,  posterior  and  total  keratocyte  density
n  the  different  studies  published  in  the  scientiﬁc  literature.
rie  et  al.5 conﬁrmed  that  after  5  years  of  PRK  there  were
vidences  of  keratocyte  density  loss  in  middle  and  posterior
troma.  They  observed  a  reduction  of  20%--24%  in  the  pos-
erior  stroma  (P<.05)  although  they  claimed  that  this  loss
as  not  completely  evident.  Keratocyte  density  in  the  ante-
ior  10%  of  the  stroma  continues  to  decrease  5%  per  year
etween  1  and  3  years  after  PRK.2 Erie2 reported  a  pro-
ressive  decline  in  anterior  stromal  keratocytes,  becoming
igniﬁcant  at  36  months  after  PRK  (P=.02).  In  contrast,  mid-
le  and  posterior  keratocyte  densities  remained  unchanged
etween  1  and  3  years  after  PRK.2 In  another  study,  Erie
t  al.10 proved  that  the  keratocyte  density  in  the  anterior
0%  of  the  stroma,  decreased  at  6,  12,  24  and  36  months
41%,  40%,  43%,  45%;  respectively)  after  PRK,  compared
o  pre-PRK.  In  a  posterior  longer-term  study,  Erie  et  al.5
emonstrated  a  similar  decreasing  pace  in  anterior  kerato-
yte  density:  40%,  42%,  45%,  and  47%  at  6 months,  2  years,
 years,  and  5  years  (P<.001).  Amoozadeh  et  al.40 found
 reduction  in  keratocyte  density  6 months  after  surgery,
ut  the  loss  was  similar  for  LASIK  and  PRK  interventions:  in
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nterior  stroma,  34.7%  versus  31.13%  (P>.05)  and  posterior
troma  0.31%  versus  0.02%,  (P>.05),  respectively.  However,
ther  studies  have  seen  differences  between  PRK  and  LASIK,
robably  associated  with  the  more  superﬁcial  ablation  in
RK.5,25,40 The  consequences  of  keratocyte  density  loss  after
RK  are  still  unknown,  but  the  visual  acuity  and  corneal
larity  seem  to  be  preserved.5
After  the  initial  depletion  of  anterior  stromal  kerato-
ytes,  an  increase  in  the  keratocyte  density  is  observed  over
ime,  probably  secondary  to  mitosis,  cellular  migration,  or
eproduction  of  keratocytes  and  myoﬁbroblasts.5,9,10,34,51,86
ollowing  apoptotic  keratocyte  loss,  the  ﬁrst  morphological
hanges  of  remaining  keratocytes  that  can  be  histologi-
ally  observed,  are  an  increase  in  cell  size  and  an  increase
n  the  size  and  the  number  of  nucleoli,  rough  endoplas-
atic  reticula,  mitochondria,  free  ribosomes  and  Golgi
omplexes,  indicating  an  active  state.87 These  keratocytes
uickly  repopulate  the  anterior  stroma,  and  return  to  simi-
ar  preoperative  levels.2,5,10,34 Several  studies  using  confocal
icroscopy  have  analyzed  the  keratocyte  density  after  PRK.
orbett  et  al.88 found  that  at  2  days  after  PRK  the  anterior
eratocyte  density  was  increased  50%,  100%  at  1  month,  and
eturned  to  preoperative  levels  at  6  months.  Frueh  et  al.85
oncluded  that  the  anterior  keratocyte  density  increased
5%  at  1  and  4  months  after  PRK,  and  returned  to  preop-
rative  levels  1  year  after  PRK.  Similarly,  Erie  et  al.  found
n  increase  of  20%  in  the  anterior  stroma  at  3  months  after
RK.2,89 According  to  the  results  of  Corbett  et  al.88 and  Erie
t  al.,10 anterior  keratocytes  proliferation  begins  1  month
fter  PRK,  with  a  pick  at  3  months,  and  return  to  preopera-
ive  levels  at  6  months.
orneal Haze
orneal  haze  reduces  corneal  transparency  at  variable
egrees.90,91 Subepithelial  haze  occurs  in  all  patients  1
onth  after  PRK,  reaching  the  greatest  intensity  at  3--6
onths,  and  gradually  decreases  from  then  on.2,8,34,92 Yet,
ome  authors  afﬁrm  that  it  begins  to  decrease  at  12--24
onths  after  PRK.8,92 Corneal  haze  is  more  common  after
orrection  of  high  myopia  (>−6.00  D),  and  it  is  rarely  seen
fter  correction  of  <−6.00  D  of  myopia  or  <+4.00  D  of
yperopia.43,71,91 Besides  the  ablation  depth,  the  severity  of
orneal  haze  is  correlated  with  excessive  ocular  UV-B  radia-
ion,  duration  of  the  epithelial  defect,  postoperative  steroid
reatment,  male  sex  and  with  certain  population  with  brown
ris.2,16,19,21,24,28,71,81,86,93--95 PRK  presents  higher  corneal  haze
ncidence  than  LASIK,  probably  because  of  the  destruction  of
he  basement  membrane.8,45,52 In  the  presence  of  damaged
pithelial  cells  and  basement  membrane,  cytokines  and
rowth  factors  can  easily  ﬂow  from  epithelium  to  anterior
troma.45,96 Cytokines  released  from  epithelial  cells  activate
eratocytes,  as  mentioned  in  a  previous  section,  which  syn-
hesize  large  diameter  collagen  ﬁbrils.8,11,33,73,81 Abnormally
eposited  extracellular  matrix  implies  the  development  of
orneal  opacity.69 Moreover,  active  keratocytes  present  a
igh  reﬂectance  that  also  contributes  to  the  decrease  in
orneal  transparency.  In  addition,  subepithelial  vacuolation,
eposit  materials  like  proteoglycans,  hyaluronic  acid  and
ollagen  Type  IV  are  involved  in  the  formation  of  the  corneal
aze  in  advanced  stages.33,77 Plasminogen  activator--plasmin
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ystem  degrades  the  damaged  ECM,  and  extended  low  lev-
ls  beyond  the  third  day  after  PRK  causes  corneal  haze
ormation.97 Guerriero  et  al.58 afﬁrm  that  the  loss  of  colla-
en  type  IV  is  related  to  the  activation  of  keratocytes  in  vivo
nd  in  vitro,  and  Winkler  et  al.33 and  Mohrenfels  et  al.98
mphasize  on  the  role  of  type  IV  collagen  in  the  develop-
ent  of  corneal  cloudiness.  Secondary  ultraviolet  B  (UV-B)
xposure,  originating  from  sun  or  solarium  is  a  causal  factor
or  aforementioned  abnormal  proteoglycan  deposition  and
ssociated  augmented  corneal  thickness.99
On  the  other  hand,  myoﬁbroblast,  derivatives  of  TGF-
eta  responding  keratocytes,  are  thought  to  be  the  ﬁrst
iological  event  for  corneal  haze  formation.51,93,94 Myo-
broblasts  play  an  essential  role  in  the  recovery  of
he  corneal  integrity  after  penetrating  injury,  mainly  in
dvanced  stages.22 They  secrete  extracellular  matrix,  con-
ract  wounds  and  have  the  ability  to  generate  adhesion
tructures  with  the  surrounding  substrate.71 TGF-beta  also
nduces  the  expression  of  connective  tissue  growth  fac-
or  (CTGF),  which  mediates  collagen  synthesis,  and  along
ith  myoﬁbroblasts  regulates  the  corneal  wound  healing,
nd  may  promote  scar  formation.100 After  PRK,  myoﬁbro-
lasts  appear  as  a  pathological  response  to  injury,71 and
heir  decreased  transparency  roots  in  the  low  intracel-
ular  content  of  crystalline.101 Irregular  surface  has  also
een  related  to  high  incidence  of  corneal  haze,94,102 and
igher  irregularity  is  seen  with  increasing  dioptric  cor-
ections  in  PRK.103 Interestingly,  surface  irregularity  is
ositively  correlated  with  myoﬁbroblast  density  in  the  ante-
ior  stroma.43 In  normal  corneal  wound  healing,  complete
egeneration  of  the  basal  membrane  after  PRK  occurs  within
--8  weeks  in  rabbits,104 which  limits  the  access  of  growth
actors  to  the  stroma69 and,  consequently,  myoﬁbroblasts
ommit  apoptosis46 modulated  by  IL-1.47 Therefore,  the
resence  of  myoﬁbroblast,  and  subsequent  corneal  haze,
s  largely  dependent  upon  the  restoration  of  the  basement
embrane.43,105
Corneal  haze  has  been  traditionally  measured  in  the  slit-
amp,  and  graded  with  diverse  scales,  like  Hanna’s  scale.
he  new  technology  leads  us  to  use  automated  instruments
or  corneal  haze  measurement.  In  vivo  confocal  microscopy
s  a  reliable  tool,  as  far  as  standardized  methods  are
sed.106 It  is  the  most  widely  used  objective  method  in
linical  setting  for  haze  measurement.  In  the  last  years,
lternative  techniques  have  come  out.  Confocal  imaging  of
econd  harmonic-generated  (SHG)  signals  has  been  shown
o  be  sensitive  in  measuring  corneal  ﬁbrosis  after  refractive
urgery.107 Recently,  the  densiometry  program  of  Pentacam
cheimpﬂug  imaging  system  (Oculus  Optikgeräte  GmbH)  has
een  proved  to  be  a  useful  method  for  measuring  corneal
aze.108
isual  Disturbances  of  Corneal  Haze
he  corneal  haze  produces  a  reduction  of  low  contrast  visual
cuity  and  night  vision  symptoms  that,  in  the  vast  majority  of
ituations,  improve  with  time.67 It  is  possible  to  see  corneal
aze  formation  after  PRK  by  means  of  confocal  microscopy,
bserved  as  a  decrease  in  the  contrast  of  the  image  and
n  increase  in  reﬂectivity.81 Böhnke  et  al.81 using  a  Tandem
canning  confocal  microscopy,  correlated  corneal  haze  and
s
o
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nterior  stromal  reﬂectivity.  However,  the  tandem  scanning
onfocal  microscopy  is  not  able  to  detect  acellular  regions
f  the  anterior  stroma  early  after  PRK  when  epithelium
nd  sub-basal  plexus  are  not  formed.10 Although  corneal
aze  in  humans  is  less  pronunced  than  in  animal  models,  if
orneal  haze  persists  and  affects  signiﬁcantly  to  the  corneal
ransparency,  it  causes  light  scatter.4,94,109 For  this  reason,
orneal  haze  may  be  described  and  analyzed  through  back
ight  scattering  (backscatter).81,110 It  also  causes  irregular
stigmatisms,2,34,93 and  subsequent  loss  of  corrected  dis-
ance  visual  acuity  (CDVA).86
The  regression  of  the  refractive  error  may  be  produced
y  epithelial  irregularity,  alterations  in  the  keratocyte  den-
ity  or  subepithelial  deposits.  Myopic  regression  occurs  in
8%  of  eyes  in  the  ﬁrst  12  months  after  PRK.2 Table  3  shows
he  mean  spherical  equivalent  changes  reported  in  differ-
nt  scientiﬁc  studies.  In  the  ﬁrst  week  after  PRK,  epithelial
rregularity  causes  a  reduction  in  visual  quality.88 During  the
rst  month,  altered  keratocytes  decrease  contrast  sensitiv-
ty,  mainly  in  high  frequencies,  and  cause  glare.  During  the
ext  2  months,  subepithelial  deposits  produce  a  decrease  in
ontrast  sensitivity,  especially  in  low  frequencies.4,88 Ginis
t  al.4 reported  that  subepithelial  deposits  are  the  ﬁrst  fac-
or  that  contributes  to  the  development  of  corneal  scatter.
he  visual  quality  is  affected  temporarily,  although  there
s  evidence  that  in  some  cases  it  persists  for  more  than  1
ear.43,91 In  order  to  avoid  a decrease  in  the  visual  qual-
ty,  all  postoperative  efforts  must  go  oriented  to  control
he  subepithelial  matter.88 The  corneal  epithelium  does  not
eem  to  contribute  signiﬁcantly  to  the  refractive  change
fter  PRK,  although  some  studies  suggest  that  epithelial
hickening  may  produce  myopic  regression,2 even  5  years
fter  PRK.90 Moller-Pedersen  et  al.55 and  Cua  and  Pepose92
uggested  that  new  keratocytes  growth  in  central  cornea  or
ostoperative  corneal  scarring  is  likely  to  be  the  main  causes
f  myopic  regression  in  ablations  of  6  mm.  In  agreement
ith  this  hypothesis,  Moller-Pedersen  et  al.55 demonstrated
hat  hyperopic  changes  were  the  direct  result  of  a  stro-
al  thinning.  Erie2 found  an  increase  of  12  m  of  epithelial
hickness  at  12  months  after  PRK  that  was  associated  with
 myopic  regression  of  −0.41  diopters  but  no  correlation
as  found  between  stromal  thickening  and  myopic  regres-
ion;  however,  the  combined  effect  of  epithelial  and  stromal
hickening  was  correlated  with  myopic  regression.
egeneration of Corneal Innervation
he  cornea  is  the  most  innervated  tissue  of  the  human
ody,7 and  these  sensory  nerves  are  derived  from  the  oph-
halmic  branch  of  the  trigeminal  nerve  ﬁbers.2,111 Corneal
ensory  nerves  penetrate  the  limbus  and  form  nerve  bun-
les  in  the  anterior  third  of  the  stroma.  Once  there,  they
un  perpendicularly  to  cross  Bowman’s  membrane,  and  form
he  sub-basal  nerve  plexus  as  a network  between  the  basal
pithelial  cells  and  Bowman’s  layer  (Fig.  2).49,111 Corneal
erve  ﬁbers,  if  visualized  using  confocal  microscopy  in  nor-
al  conditions,  show  high  reﬂectivity  across  the  cornealtroma  with  a  rectilinear  pattern.  Subepithelial  nerve  ﬁbers,
n  the  other  hand,  are  thinner  than  stromal  nerve  ﬁbers.
orneal  ﬁbers  are  considered  primarily  nociceptive  (70%),
ollowed  by  mechanosensitive  ﬁbers  (20%).112 In  PRK,  pho-
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Table  3  Mean  Spherical  Equivalent  After  Surgery,  Mean±SD  or  Range  (Diopters).
Study  Technique Preop 1  month 6  months 1  year 2  years  3  years  5  years  7  years
Einollahi  et  al.
(2011)63
PRK+MD  −2.42±0.75
(−4.13  to  −1.13)
−0.34±1.00
PRK+AAD  −2.38±0.72
(−4.00  to  −1.25)
−0.28±0.91
Wallau  and
Campos  (2008)159
LASIK  −3.99±1.20
(−1.46  to  −6.96)
0.49±0.52
(−0.50  to  1.50)
PRK+MMCa −3.85±1.12
(−1.95  to  −6.40)
0.61±0.61
(−0.50  to  2.88)
Ghirlando  et  al.
(2007)3
PRK  −  4.37±1.35 −0.37±0.61 −0.27±0.31
LASEK  −3.95±1.29 +0.22±0.79 −0.17±0.35
Nassaralla  et  al.
(2007)28
PRK+MMCb −2.72±0.76
(−1.50  to  −4.00)
−0.08±0.38
(−0.75  to  −0.75)
−0.18±0.35
(−0.75  to
−0.50
Patel et  al.
(2007)25
LASIK  −6.5±2.5
(−11.0  to  −2.0)
−0.1±0.5
(−1.0  to+1.0)
−0.2±0.5
(−1.25
to+0.75)
−  0.2±0.4
(−1.0
to+0.62)
−0.2±0.4
(−1.0
to+0.75)
−0.2±0.5
(−1.37
to+0.37)
−0.4±0.5
(−1.25
to+0.25)
PRK −3.7±1.4
(−5.75  to  −1.25)
−0.1±0.3
(−0.5  to+1.0)
−0.3±0.3
(−0.87  to
plano)
−0.4±0.4
(−1.25
to+0.25)
−0.3±0.2
(−0.75  to
plano)
−0.6±0.4
(−1.25  to
plano)
−0.5±0.4
(−1.0  to
plano)
Lee et  al.  (2005)18 PRK  −5.17±1.53
(−2.00  to  −9.13)
0.24±0.61 −0.46±1.01
tPRK  −5.11±.51
(−1.87  to  −9.50)
0.59±0.78 0.18±0.91
LASEK  −5.26±2.58
(−1.50  to  −9.50)
0.13±0.62 −0.82±1.18
Kozak  et  al.
(2003)56
LASIK  −6.00 −0.48±0.30
(−0.16  to  −1.10)
PRK −6.00 −0.67±0.35
(−0.21  to  −1.21)
PRK, photorefractive keratectomy; MD, mechanical debridement; AAD, alcohol-assisted debridement; LASIK, laser in situ keratomileusis; MMC, mitomycin C; LASEK, laser-assisted
subepithelial keratectomy; tPRK, trans-PRK.
a (0.002%, 1 min).
b (0.02%, 2 min).
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nigure  2  Schematic  representation  of  corneal  stromal  nerve
ection.
oablation  severs  nerves  of  the  subbasal  plexus  and  anterior
troma.2,83 It  has  been  suggested  that  axotomy  of  corneal
erves  might  cause  the  decrease  in  keratocyte  density  after
RK,113,114 corneal  nerves  directly  innervate  keratocytes  and
rovide  trophic  support  in  normal  conditions.115
Animal  studies  have  proved  that  the  regeneration  of  the
orneal  nerves  after  PRK  occurs  as  a  biphasic  process.  In  the
rst  stage,  a  subbasal  plexus  originates  from  the  cut  end  of
ubepithelial  plexus,  and  the  ﬁne  neurites  run  centrally  with
igrating  cells.116,117 In  the  next  phase,  this  transient  plexus
egenerates,  and  stromal  originated  nerves  take  place.117
ubbasal  nervous  plexus  can  have  a  signiﬁcant  inﬂuence
n  the  regulation  of  epithelial  healing.14 Substances  like
hemokines,  proteases  and  neuropeptides  are  released  after
orneal  injury,8,24,25,50,51,118 and  it  is  postulated  that  neu-
opeptides  like  substance  P  (SP)  and  calcitonin-gene  related
eptide  (CGRP)  contribute  to  corneal  wound  healing.112
orneal  nerves  also  inﬂuence  the  production  of  collagen
ype  VII,  necessary  for  the  anchoring  of  the  epithe-
ium  to  the  stroma.119 Conversely,  injured  epithelial  cells
elease  nerve  growth  factor  (NGF)  that  stimulates  nerve
egeneration.
Approximately,  at  8  weeks  after  PRK,  sub-epithelial  nerve
bers  are  visible  on  the  edges.  Erie,2 using  tandem  scan-
ing  confocal  microscope,  visualized  subbasal  nerve  ﬁber
undles  in  17%  of  the  corneas  at  1  month  after  PRK.  How-
ver,  he  noted  that  the  density  of  these  nerve  ﬁbers  was
8%  less  than  preoperatively.2 After  about  3  months  of
he  surgery,  no  branched  nerve  ﬁbers  can  be  visualized
n  the  center  of  the  zone  of  ablation.  Changes  in  subep-
thelial  plexus  and  stromal  trunks  begin  to  appear  2--4
onths  postoperatively.8 At  6--8  months  after  the  inter-
ention  of  PRK  subepithelial  nerve  regeneration  is  almost
omplete,8,111,120 although  changes  in  the  structure  of  the
orneal  nerves  can  be  appreciated  by  confocal  microscopy
p  to  12  months  postoperatively.120 However,  nerve  den-
ity  continues  to  improve  until  12  months  after  surgery,  and
eturns  to  the  preoperative  values  at  2  years.121 According
p
n
t
o subbasal  plexus  in  human  cornea.  (A)  Frontal  view.  (B)  Cross
o  Moilanen  et  al.122 in  71%  of  cases  the  central  branch-
ng  postoperatively  was  comparable  to  control  subjects  at
 years  (P=.56).  Erie2 proved  that  subbasal  nerve  density
as  reduced  at  3,  6  and  12  months  (87%,  75%,  60%,  respec-
ively)  after  PRK,  and  returned  to  preoperative  levels  at  24
nd  36  months  postoperatively.  Subsequently,  Erie  et  al.83 in
 prospective  5-year  longitudinal  clinical  trial,  proved  with
onfocal  microscopy  that  the  recovery  of  subbasal  nerve
ensity  in  central  cornea  was  faster  in  PRK  than  in  LASIK.  The
uthors  observed  that  subbasal  corneal  density  was  reduced
y  59%  at  1  year  after  PRK  (2764±1321  m/mm2) compared
o  preoperatively  (6786±1948  m/mm2;  P<.001).  Sub-basal
ervous  plexus  was  almost  recovered  2  years  after  PRK
6242±1763  m/mm2),  and  remained  unchanged  at  3  years
6358±2447  m/mm2) and  5  years  (5903±3086  m/mm2).83
n  LASIK,  they  observed  that  subbasal  corneal  density  was
educed  by  34%  at  3  years  (P<.001),83 with  values  at  5  years
ostoperatively  comparable  to  those  obtained  preopera-
ively  (5903±3086  m/mm2).83 It  is  worth  to  note  that  in
his  study,  the  corneal  ﬂap  was  created  using  a  mechani-
al  microkeratome.83 As  the  new  technology  allows  making
orneal  ﬂaps  with  laser  instead  of  with  a  mechanical  micro-
eratome,  it  is  possible  that  studies  in  the  near  future  report
 faster  corneal  nerve  recovery  after  LASIK.
When  the  process  of  corneal  nerve  regeneration  ﬁnal-
zes,  morphological  abnormalities  are  often  observed.8,83,122
ccording  to  Erie,2 in  the  ﬁrst  6  months  after  PRK  the  central
ubbasal  nerves  are  organized  in  horizontal  or  oblique  ori-
ntation.  However,  between  6  and  12  months,  the  subbasal
erve  orientation  rotes  and  comes  to  vertical  orientation.  In
ry  eye  conditions,  Esquenazi  et  al.22 observed  active  ker-
tocytes,  and  they  expressed  nerve  growth  factor  (NGF).
GF  stimulates  the  proliferation  of  basal  epithelial  cells  in
ormal  conditions.  Active  keratocytes  provoke  an  overex-
ression  of  NGF,  which  leads  to  abnormal  ﬁndings  in  corneal
erves,  such  as  hypertrophy.22 They  also  found  higher  nerve
ortuosity,  higher  number  of  nerve  beads,  and  the  presence
f  nerve  sprouts  in  desiccating  environment  group,22 which
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means  there  is  a  high  metabolic  activity  to  repair  the  alter-
ations  in  the  corneal  epithelium.
Corneal  Pain  and  Sensitivity
Photoablation  severs  corneal  nerves,  disrupting  the  lacrimal
functional  unit  (LFU).  LFU  is  constituted  by  the  lachry-
mal  gland,  ocular  surface  and  innervation.  It  regulates  tear
secretion,  and  affects  its  composition.123 Thereby,  photoab-
lation  produces  transitory  dry  eye,  deterioration  of  corneal
barrier  function  and  alteration  in  corneal  sensitivity.83,111,124
A  reduction  of  the  tear  ﬂow  after  PRK  has  been  proved
using  Schirmer  test.124 According  to  Erie  et  al.,83 LASIK
presents  higher  prevalence  of  postoperative  dry  eye,  altered
corneal  epithelium  and  tear  ﬁlm  than  PRK.  Dry  eye  has
been  associated  with  low  corneal  sensitivity.125,126 Differ-
ent  devices  are  available  to  measure  corneal  sensitivity,
as  Cochet--Bonnet  esthesiometry  or  non-contact  gas  esthe-
siometer.  Cochet--Bonnet  esthesiometer  only  stimulates
mechanosensory  ﬁbers,  whereas  non-contact  gas  esthe-
siometer  measures  activation  thresholds  of  nociceptors
using  controlled  chemical,  thermal  and  mechanical  pulses.
Non-contact  gas  esthesiometer  is,  therefore,  a  more  sensi-
tive  device  for  measuring  alterations  in  corneal  sensitivity.
Still,  Coche--Bonnet  esthesiometry  is  more  widely  used,
and  controversy  remains  about  the  time  course  of  the
corneal  sensitivity  recovery  after  PRK  with  this  device.
Kauffmann  et  al.120 afﬁrm  that  the  recovery  of  corneal
sensitivity  usually  starts  at  4--6  weeks,  completing  approx-
imately  within  6--12  months  following  PRK.  However,  Erie
et  al.83 claim  that  the  recovery  of  corneal  sensitivity  is
completed  from  3 months  to  1  year  after  PRK.  Hypoes-
thesia  is  often  expected  until  3  months  after  surgery,  due
to  the  loss  of  corneal  nerves.8 On  the  other  hand,  Gallar
et  al.127 measured  corneal  mechanical  and  chemical  sensi-
tivity  following  PRK  with  non-contact  gas  esthesiometer,  and
found  that  both  types  of  sensitivities  were  reduced  even  5
years  postoperatively,  achieving  normal  values  in  10  years.
Despite  the  diminished  corneal  sensitivity,  intense  pain  is
usually  present  hours  after  PRK.128 Gallar  et  al.129 attributed
corneal  pain  and  discomfort  sensations  to  the  altered  func-
tionality  of  corneal  nerves.  They  recorded  spontaneous
activity  and  modiﬁed  responsiveness  in  corneal  ﬁbers  of
cats  that  underwent  PRK.129 Experimental  evidences  sup-
port  the  idea  that  ongoing  activity  evokes  spontaneous  pain
sensations.130,131
Acceleration of Corneal Regeneration Process,
Reduction of Corneal Haze and Corneal Pain
Management
Nowadays  there  are  several  alternatives  to  speed  up  the
process  of  epithelial  regeneration,  like  epithelial  removal
techniques,  amniotic  membrane,  or  bandage  contact  lenses.
In  PRK,  agents  like  mytomicin-C  (MMC)  or  ﬂuoroquinones
that  reduce  the  corneal  haze  formation  are  used,  and
drugs  to  reduce  the  corneal  pain  and  inﬂammation  are
also  prescribed.
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pithelial  Removal  Techniques
n  PRK,  previous  to  the  impact  of  laser  energy  over  the
ornea,  the  corneal  epithelium  has  to  be  removed.  The
emoval  of  the  corneal  epithelium  is  carried  out  mainly
ith  epithelial  mechanical  scraping  using  chemical  agents
ike  diluted  ethanol  solution,9 through  a  rotary  brush  or
sing  the  laser  itself  -- known  as  transepithelial  ablation
Fig.  3).18,21,22,39,63,128,132,133 The  epithelial  scraping  has  post-
perative  adverse  effects  like  pain,  myopic  regression  or
orneal  haze.  Some  modiﬁcation  in  PRK  technique  can  alter
he  wound  healing  response  with  the  aim  of  minimizing  the
dverse  effects.25 The  exposition  to  agents  such  as  ethanol
an  produce  an  increase  in  the  inﬂammatory  response  and
ore  damage  to  the  anterior  stromal  keratocytes  that
ould  increase  the  haze  formation.21,94 Yet,  controversy
emains  in  the  scientiﬁc  literature  because  other  authors
fﬁrm  that  alcohol-assisted  epithelial  removal  produces
ess  inﬂammation,  favoring  epithelial  regeneration  and
reventing  corneal  haze  or  keratoyce  apoptosis.9,63 Esque-
azi  et  al.22 proved  that  the  epithelial  scraping  might  be
ssociated  with  an  increase  in  the  number  of  reﬂective
tructures  in  the  stroma,  mainly  in  corneas  with  ocular
ryness  after  PRK.  The  laser-scrape  epithelial  removal
ecreases  the  degree  of  keratocyte  apoptosis,  producing  a
ess  pronounced  loss  of  superﬁcial  keratocytes.2 However,
he  irrigation  with  cold  balanced  salt  solution  (BSS)  may
lter  the  keratocyte  apoptosis  in  the  retroablation  zone.2
he  time  necessary  for  mechanical  debridement  is  greater
han  the  time  required  for  laser  or  alcohol  scrape  tech-
iques,  even  for  expert  surgeons.18 Mechanical  debridement
s  related  to  stromal  dehydration  and  disappearance  of
nterior  stromal  keratocytes.18,63 This  loss  provokes  an
ncrease  of  cells  in  the  underlying  stroma,  causing  stromal
yperplasia  and  haze  formation.134 Einollahi  et  al.63 found
aster  mean  epithelial  healing  time  in  the  alcohol-assisted
roup  than  in  the  mechanical  group  (3.0±0.3  versus
.2±0.4  days,  P=.001).  They  observed  greater  anterior
etroablation  stromal  keratocyte  density  in  the  mechanical
roup  than  in  the  alcohol-assisted  groups  at  3  months
704.3±119.9  cells/mm2 versus  743.3±103.7  cells/mm2,
=.05)  and  at  6  months  (643.8±134.4  cells/mm2 versus
96.7±129.6  cells/mm2, P=.02).63 In  the  same  study,
ahram  et  al.  did  not  found  statistically  signiﬁcant  differ-
nces  in  middle  and  posterior  keratocyte  density  between
he  mechanical  and  alcohol-assisted  groups.63 They  also
roved  that  mechanical  and  alcohol-assisted  epithelial
ebridement  after  PRK  present  similar  visual  and  refractive
utcomes  in  patients  with  mild  myopia,63 in  agreement
ith  the  results  of  Goreishi  et  al.135 They  reported  similar
afety  and  efﬁcacy  with  alcohol-assisted  and  mechanical
ebridement  in  a  1250  eye  sample,  but  anterior  keratocyte
ensity  was  not  assessed  in  this  study.135
Laser-assisted  subepithelial  keratomileusis  (LASEK)  was
eveloped  in  order  to  reduce  corneal  pain  and  haze  forma-
ion  associated  with  PRK,  and  to  accelerate  visual  recovery.
pithelial  delamination  with  diluted  alcohol  showed  in  an
lectron  microscope  study  that  was  able  to  leave  a  smooth
urface,  ideal  for  LASEK  intervention.136 It  seems  that  a
egular  surface  before  laser  application  helps  corneal  heal-
ng  and  prevents  haze.137 Chen  et  al.138 contrasted  these
ndings  in  a later  study,  and  showed  a  high  variability
158  J.  Tomás-Juan  et  al.
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presses  TGF-beta1,  collagen  III  and  ﬁbronectin.150 Takenigure  3  TransPRK  (transepithelial  photorefractive  keratecto
f Schwind  Eye-Tech-Solutions).
n  morphological  changes  after  diluted  alcohol  treatment,
ependent  upon  concentration  and  time.  Cell  viability  was
ffected  when  alcohol  exceeded  its  concentration  by  25%  or
5-s  exposure.138 Yet,  these  studies  have  been  conducted
n  vitro,  and  the  complex  interactions  of  tear  ﬁlm  and
orneal  surface  were  not  considered.  In  vivo  studies  do
ot  show  any  difference  between  LASEK  and  PRK.139 Lee
t  al.18 evaluated  epithelial  healing,  postoperative  pain
nd  visual  outcomes  using  epithelial  mechanical  (conven-
ional  PRK),  transepithelial  PRK  and  20%  diluted  alcohol
aser-assisted  subepithelial  keratomileusis  (LASEK)  with  ﬂap
epositioning.  After  6  months,  they  found  little  differences
n  clinical  outcomes  between  the  3  techniques,  noting  a
light  overcorrection  in  the  transepithelial  PRK  and  slight
ndercorrection  in  LASEK.  Corneal  pain  and  subepithelial
aze  results  were  similar.18 Subsequently,  Ghanem  et  al.139
roved  in  a  prospective  randomized  double-masked  study
hat  the  reepithelialization  was  faster  in  a  PRK  group
ompared  with  a  butterﬂy  LASEK  group,  even  though  epithe-
ial  semi-discs  were  repositioned  intraoperatively  in  LASEK
roup.  (4.35±0.48  days  versus.  4.75±0.72  days,  P=.002).
hey  also  found  lower  pain  level  in  PRK  group,  but  pain
cores  and  ocular  discomfort  were  not  statistically  differ-
nt  from  butterﬂy  LASEK  (3.31±4.09  versus.  4.43±4.27;
=.18).139
It  has  been  proven  in  animal  studies  that  transepi-
helial  ablation  produces  a  uniform  surface  for  corneal
egeneration,  and  prevents  keratocyte  apoptosis,36 reduc-
ng  the  risk  of  corneal  haze.21,72 Wang  et  al.140 presented
romising  preliminary  results  of  SCHWIND-ESIRIS  excimer
aser  for  transepithelial  ablation,  but  the  ﬂawed  design
f  the  study  makes  difﬁcult  to  assess  the  real  value  of
his  technique.  Later,  Aslanides  et  al.21 proved  in  humans
hat  transepithelial  ablation  was  safer  than  the  epithelial
t
e
son  the  Schwind  Amaris  1050  RS  laser  platform  (with  permission
echanical  scraping  using  chemical  agents  as  alcohol,  as
t  provides  a  faster  epithelial  healing,  less  postoperative
ain  and  less  corneal  haze  at  1  week  (P=.07),  and  at
,  3,  and  6  months  after  surgery  (P<.05).  In  addition,
hey  observed  an  improvement  of  3  Snellen  lines  in  visual
cuity  on  day  3  in  the  modiﬁed  transepithelial  PRK  (all-
urface  laser  ablation)  group  compared  to  conventional
lcohol-assisted  PRK  group  (0.4  versus  0.2;  P<.05).21 Trans-
pithelial  ablation  also  resulted  in  better  corrected  distance
isual  acuity  (DCVA)  than  conventional  alcohol-assisted  PRK
33%  versus  13%,  respectively,  P>.05),21 although  differ-
nces  in  higher  order  aberrations  were  not  statistically
igniﬁcant.21
mniotic  Membrane  Transplantation
part  from  the  above  mentioned  techniques,  amniotic  mem-
rane  transplantation  reduces  the  inﬂammation  after  PRK,
revents  polymorphonuclear  cell  inﬁltration,  produces  less
eroxidation,  avoids  keratocyte  apoptosis  and  stimulates
orneal  epithelialization.37,77 It  is  usually  combined  with
RK  to  treat  corneal  dystrophies,  corneal  degenerations,
cars,  keratopathies,141,142 or  even  to  treat  corneal  haze
econdary  to  PRK.143 The  amniotic  membrane  restricts  the
nﬂux  of  polymorphonuclear  cells  (PMC)  to  the  patch.144,145
MCs  adhere  to  the  amniotic  membrane  and  eventually
ommit  apoptosis.146 This  is  a physiological  way  of  sup-
ressing  corneal  inﬂammation.147 In  addition,  amniotic
embrane  has  intrinsic  keratocyte  growth  factors,  EGF  and
eurotrophins  that  promote  epithelization.148,149 It  also  sup-ogether,  amniotic  membrane  has  a  potent  anti-scarring
ffect  that  reduces  corneal  haze  formation,  as  demon-
trated  in  animal  studies.144,151
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Agents  to  Enhance  Wound  Healing
The  wound  healing  response  may  be  altered  by  the  prophy-
lactic  application  of  a  topical  solution  of  mitomycin-C  (MMC)
immediately  after  the  laser  ablation,27 in  order  to  avoid
or  minimize  myoﬁbroblast  activation.8,25,40,71,86,90,133,152--154
MMC  is  an  antineoplastic  antibiotic  agent  of  the  family
of  anti-tumor  quinolones  and  derived  from  Streptomyces
caespitosus.  It  is  a  potent  DNA  crosslinker:  it  inhibits  the
replication  of  deoxyribonucleic  acid  (DNA).28,32,91,93,155--159
Thereby,  MMC  inhibit  cell  mitosis,  including  epithelial  and
stromal  cells.8,34,86,93,133,155,157,160,161 Mitomycin-C  decreases
corneal  haze  compared  to  corticosteroid  treatment,82 and,
consequently,  improves  visual  acuity.152 Its  use  is  specially
indicated  in  high  myopia  (≥−6.00  D)  and  deeper  abla-
tion  depths  (≥75  m).82,86,90,133,155,160 Wallau  and  Campos162
obtained  better  UCVA  and  BSCVA  with  the  combination  of
PRK  with  MMC,  than  with  LASIK  (P=.027  and  P<.001,  respec-
tively)  at  3,  6 and  12  months  after  surgery.  Goreishi  et  al.163
reported  an  incidence  of  4%  of  corneal  haze  at  1  year  post-
operatively  with  intraoperative  application  of  0.02%  MMC,  in
a  sample  with  a  mean  refractive  error  of  −5D.  Fazel  et  al.164
found  that  two-step  administration  of  0.02%  MMC  (45  s,  fol-
lowed  by  15  s)  further  decreased  corneal  haze  formation  in
high  myopia,  compared  to  a  single  dose  of  45  s.  The  ben-
eﬁts  of  MMC  have  also  been  described  once  the  haze  has
been  established,  where  mechanical  epithelial  scraping  and
instillation  of  MMC  restores  corneal  transparency.165
Although  the  application  of  the  mitomycin  C  is  helpful
for  corneal  recovery,  it  is  necessary  to  control  the  doses  and
the  time  of  exposure.20 According  to  Thornton  et  al.133 the
concentration  is  a  more  important  factor  than  the  duration
of  MMC  exposure  in  corneal  haze  prevention.  Rajan  et  al.34
analyzed  the  effects  of  MMC  after  correction  of  −9.00
diopters  by  PRK  in  3  groups  of  human  corneas:  without  MMC
application,  with  MMC  (0.2  mg/mL)  application  for  1  min  and
with  MMC  (0.2  mg/mL)  application  for  2  min.  The  2  min  MMC
group  (0.2  mg/mL)  had  thinner  epithelium  than  the  1  min
and  without  MMC  application  groups  (P<.0001).  The  applica-
tion  of  the  intraoperative  MMC  lasts  between  10  s  and  120  s,
depending  on  the  surgeon.11 According  to  Khoury  et  al.156 the
application  of  intraoperative  MMC  vary  from  12  s to  5  min.
Shojaei  et  al.153 afﬁrm  that  short-time  MMC  exposure  pre-
vents  low-grade  haze  in  low  ablation  depths.  The  MMC  doses
oscillate  between  0.002%  and  0.06%.156 The  intraoperative
application  of  0.02%  MMC  solution  is  the  most  recommended,
as  it  produces  less  corneal  haze,  and  provides  better  uncor-
rected  visual  acuity  (UCVA)  and  best  spectacle-corrected
visual  acuity  (BSCVA).124,166,167 Still,  Ramjoo  et  al.90 found
similar  refractive  and  haze  outcomes  with  0.01%  and  0.02%
MMC  for  mild  myopia,  recommending  the  use  of  0.01%.  The
lowest  dose  available  is  recommended  to  avoid  side  effects.
Rajan  et  al.34 observed  a  delay  in  keratocyte  regeneration
after  MMC  application  (P<.0005).  Midena  et  al.82 proved  by
means  of  confocal  microscopy  that  the  application  of  0.02%
MMC  produced  a  considerable  decrease  of  anterior  stromal
keratocytes,  but  there  is  no  evidence  of  this  decline  in
the  posterior  stromal  keratocytes.  Subsequently,  Thornton
et  al.133 observed  a  keratocyte  loss  in  the  anterior  stroma  1
month  and  6  months  after  PRK  with  standard  MMC  concen-
trations  (0.02%).  Razmjoo  et  al.90 did  not  found  signiﬁcant
e
i
a159
eduction  in  keratocyte  density  after  application  of  0.02%
itomycin  C  (MMC).  The  dose  of  MMC  is  associated  with  the
rade  of  refractive  error.  Thornton  et  al.133 believe  that  for
igh  myopia  corrections  (>−6.00  D)  standard  concentration
f  topical  MMC  (0.02%)  may  be  used,  whereas  for  moderate
yopia  (−3.00  to  −5.90  D)  low  dose  of  MMC  (0.002%)  may
e  considered,  although  it  seems  that  intermediate  dose  of
MC  (0.02%)  is  more  effective  than  0.002%  for  moderate
yopia.
The  cytotoxicity  of  MMC  increases  with  cumulative
oses,161 and  when  MMC  is  combined  with  ethanol,
hich  increments  the  apoptosis  of  keratocytes.20 Few
omplications  have  been  associated  with  its  use  with  the
xception  of  a  decrease  in  the  short  term  of  the  kera-
ocyte  density.71,155,157 However,  some  complications  have
een  documented  at  the  time  of  instillation  or  after  some
eeks.  Although  unusual,  scleral  ulceration,  non-healing
onjunctivas  and  complications  associated  with  high  MMC
oses  (0.04%)  or  prolonged  postoperative  topical  use  may
ppear,86 because  high  doses  of  MMC  suppress  cellular  RNA
eplication  and  protein  synthesis.93 As  MMC  is  applied  in  the
tromal  bed,  it  seems  that  it  might  penetrate  into  the  ante-
ior  chamber,  because  cytotoxic  effects  on  the  ciliary  body
pithelium  have  been  reported.11,161 There  is  controversy  in
he  scientiﬁc  literature,  but  MMC  does  not  seem  to  cause  any
lteration  in  the  ciliary  body  or  intraocular  pressure  (IOP)
fter  PRK.161 Kymionis  et  al.161 investigated  the  effects  of
MC  after  PRK  in  40  eyes  of  20  rabbits.  They  applied  0.02%
MC  for  2  min  in  one  eye,  and  balanced  salt  solution  (BSS)
or  2  min  in  the  contralateral  eye.  After  3  months,  they  did
ot  found  differences  in  the  morphology  of  the  ciliary  body,
nd  tonometric  measurements  remained  stable  (P=.075).
The  endothelium  is  the  inner  layer  of  the  cornea.
ndothelial  cells  have  a  hexagonal  or  polygonal  shape,48
nd  they  are  homogeneously  distributed,  without  signs
f  polymegatism  and  pleomorphism  in  normal  conditions.
ndothelial  cells  are  not  able  to  regenerate,40,157 and
 reduction  in  the  number  of  cells  is  seen  with  age.
fter  PRK,  endothelial  structure,  shape  and  density  remain
naltered.81,85,168 Table  4  shows  the  variation  of  endothe-
ial  cells  in  the  different  studies  published  in  the  scientiﬁc
iterature.  Polymegatism  or  pleomorphism,  if  present,  may
e  secondary  to  still  unknown  corneal  metabolism.169 There
s  also  controversy  about  the  toxic  effect  of  MMC  in  the
verall  morphology  of  the  endothelium.8,11,86,153 Morales
t  al.158 proved  that  intraoperative  0.02%  MMC  during
0  s  after  PRK  induced  corneal  endothelial  cell  loss  at
 month  and  3  months  (P=.0006,  P=.002;  respectively).
iakonis  et  al.11 applied  Mitomycin  C  (MMC)  for  15  s  and
he  density  of  endothelial  cells  was  not  affected.  Zare
t  al.170 obtained  similar  results  when  0.02%  MMC  was
pplied  for  45  s.  Subsequently,  Shojaei  et  al.153 found
igniﬁcant  differences  of  mean  endothelial  cell  densi-
ies  in  the  MMC  group  and  in  the  control  group  at  6
onths  after  surgery  (2878.79±283.04  cells/mm2 versus
826.19±286.25  cells/mm2,  P=.25).  Undoubtedly,  after  the
pplication  of  MMC  the  DNA  of  endothelial  cells  gets
amaged.171 It  remains  to  be  determined  the  long-term
ffects  of  such  event.  According  to  Wilson,71 long-term  stud-
es  (more  than  10  years)  are  necessary  to  determine  the
dverse  effects  of  MMC.
160  J.  Tomás-Juan  et  al.
Table  4  Variation  of  Endothelial  cell  density  After  Surgery,  Mean±SD  or  Range  (cell/mm2).
Study  Technique  Preoperatively  1  month  3  months  6  months  12  months
Shojaei  et  al.
(2013)153
PRK  with  MMC  2879±298  2849±296  2878  ±  283
PRK with  BSS  2819±303  2825±283  2826  ±  286
Einollahi et  al.
(2011)63
PRK  with  MD  3102±281
(2498--3823)
2996±259  2795  ±  764
PRK with  AAD 3125±299
(2610--4276)
3011±240 2946  ±  240
Amoozadeh  et  al.
(2009)40
LASIK  3022±224  3030  ±  186
PRK 2983±293  3025  ±  404
Wallau and
Campos
(2008)159
LASIK  2709±242  2667  ±  277
PRK with  MMCb 2709±246  2686  ±  253
Diakonis et  al.
(2007)11
PRK+MMCe 2757±117  2736  ±  144  2729±131  2716  ±  136  2721±113
Epi-LASIK  2769±158  2727  ±  179  2741±177  2758  ±  176  2760±102
Nassaralla  et  al.
(2007)28
PRK  with
MMCa,c
2150±180
(1800--2650)
2100±205
(1680--2540)
2200±210
(1680--2500)
Morales et  al.
(2006)158
PRK+MMCd 2835±395  2416  ±  291  2357±404
PRK+BSS  2779±492  2711  ±  555  2746±526
PRK, photorefractive keratectomy; MMC, mitomycin C; BSS, balanced saline solution; MD, mechanical debridement; AAD, alcohol-assisted
debridement; LASIK, laser in situ keratomileusis; Epi-LASIK, epipolis laser in situ keratomileusis.
a After radial keratotomy.
b 0.002%, 1 min
c 0.02%, 2 min.
d 0.02%, 30 s.
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New  generation  quinolones,  instead  of  preventing
orneal  haze,  are  used  as  prophylactic  antibiotics  to  avoid
orneal  infections  after  refractive  surgery.172 They  also
nhance  the  rate  of  corneal  recovery.  Fourth  genera-
ion  ﬂuoroquinolones  like  gatiﬂoxacin  (Zymar,  Allergan,
rvine,  California)  and  moxiﬂoxacin  (Vigamox,  Alcon  Lab-
ratories,  Fort  Worth,  Texas)  have  been  demonstrated
o  mediate  faster  corneal  healing,172 without  evident
ifferences  between  both  of  them  in  terms  of  visual
utcomes.118
andage  Contact  Lenses
fter  PRK,  the  corneal  surface  needs  between  2  and  4
ays  to  regenerate,2 and  the  vision  may  ﬂuctuate  for  sev-
ral  weeks  to  months.  If  epithelial  regeneration  delays,  the
ubepithelial  haze  increases;  for  this  reason,  an  appropri-
te  corneal  reepithelization  is  crucial.8,105 Reepithelization
s  the  ﬁrst  step  during  corneal  regeneration  after  PRK.51
f  the  reepithelialization  is  facilitated  with  the  appropri-
te  contact  lenses,  visual  acuity  improves.30,173 Although
herapeutic  contact  lenses  have  been  used  for  more  than
0  years,  PRK  has  increased  their  popularity.23,30 One  of
he  major  disadvantages  of  PRK  is  the  pain  and  discom-
ort  during  1--3  days  after  intervention.7,15,174 To  ease  off
he  postoperative  pain  and  discomfort,  and  to  promote
O
C
a
cpithelial  healing,  bandage  contact  lenses  are  ﬁtted  for
--5  days  after  surgery.12,23,30,31 Other  techniques  and  med-
cations  has  been  proposed  in  order  to  reduce  corneal
ain  like  occlusive  pressure  patching,  but  the  bandage
ontact  lenses  are  still  the  gold  standard.173 Bandage
ontact  lenses  are  used  to  protect  the  epithelium  from
he  eyelid,  to  reduce  the  haze  formation,31,173 to  enhance
pithelial  healing,  to  control  the  sensation  of  pain,  and
o  prevent  epithelial  erosions.12,23,30,128 Faster  reepithe-
ialization  produces  a  reduction  of  discomfort,  facilitates
isual  recovery,  and  restores  the  corneal  barrier  to  prevent
nfections.12
Because  of  the  prolonged  use  of  therapeutic  contact
enses,  and  to  assure  the  proper  corneal  metabolism,  a  high
xygen  permeability  (Dk/t)  contact  lens  are  used.23,30,31,173
ilicone  hydrogel  contact  lenses  have  a  Dk/t  coefﬁcient
--10-fold  greater  than  conventional  hydrogel  lenses.12 For
his  reason,  silicone  hydrogel  bandage  contact  lenses  are
idely  ﬁtted,7,12,30,31 and  are  the  ones  approved  by  the
DA  for  prolonged  use  after  PRK.  Currently,  a variety  of
ontact  lenses  are  used  as  therapeutic  soft  contact  lenses
fter  PRK  like  Lotraﬁlcon  A  (Focus  Night  &  Day,  Ciba  Vision),
otraﬁlcon  B  (O  2  Optix,  Ciba  Vision),  Senoﬁlcon  A  (Acuvue
asys,  Vistakon  Inc.),  Balaﬁlcon  A,  Omaﬁlcon  A  (Proclear,
ooper  Vision)  and  Senoﬁlcon  A.12,23,30,31 Lotraﬁlcon  B  is
pproved  by  FDA  for  6  days  of  continuous  wear  and  Senoﬁl-
on  A  for  1  week  of  continuous  wear,  while  Lotraﬁlcon  A
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FCorneal  Regeneration  After  Photorefractive  Keratectomy  
is  approved  for  30  days  of  continuous  wear  and  therapeu-
tic  use.12,23 The  therapeutic  efﬁcacy  of  the  Lotraﬁlcon  A
after  PRK  has  been  intensively  studied,12,23,30,31 and  reduc-
tion  of  discomfort  and  faster  corneal  reepithelialization  in
48  h  have  been  described.12,23 Edwards  et  al.31 proved  that
Lotraﬁlcon  A  showed  better  best  spectacle-correction  visual
acuity  (BSCVA)  than  Omaﬁlcon  A,  without  statistically  sig-
niﬁcant  differences  in  contrast  sensitivity  or  uncorrected
visual  acuity  (UVA).  Omaﬁlcon  A  reduced  the  BSCVA  in  40.4%
of  patients  at  1  month,  whereas  Lotraﬁlcon  A  reduced  the
BSCVA  in  18.6%  of  the  patients  (P=.002).  The  corneal  pain
was  greater  with  Omaﬁlcon  A  than  with  Lotraﬁlcon  A  at  1
day  (P=.000)  and  4  days  postoperatively  (P=.027).31 In  con-
trast,  an  increase  in  corneal  inﬁltrates  with  Lotraﬁlcon  A
was  observed  compared  to  Omaﬁlcon  A,  and  there  was  not
a  statistically  signiﬁcant  difference  in  reepithelialization.31
The  authors  suggested  that  corneal  inﬁltrates  might  be  a
consequence  of  Lotraﬁcon  A’s  rigidity  due  to  its  reduced
water  content  (24%)  versus  59%  of  Omaﬁlcon  A.31 Subse-
quently,  Razmjoo  et  al.30 in  a  comparative  study,  found  that
the  58.3%  of  the  eyes  with  Senoﬁlcon  A  and  41.7%  of  the
eyes  with  Lotraﬁlcon  A  completed  the  reepithelialization  at
day  5  (P>.05).  Although  there  were  not  statistically  signif-
icant  differences  in  the  rate  of  corneal  reepithelialization
between  both  contact  lenses  (P>.05),  and  the  postopera-
tive  pain  and  discomfort  index  was  signiﬁcantly  lower  in
Senoﬁlcon  A  group  (P<.05).30 They  also  compared  the  visual
acuity  between  Senoﬁlcon  A  and  Lotraﬁlcon  A  after  PRK,  and
proved  that  in  both  groups  the  UCVA  was  worse  at  3  days  than
at  day  1.  However,  the  UCVA  improved  at  day  5,  with  97.7%
reaching  UCVA  of  20/40.  A  feasible  explanation  is  that,  at
day  3,  the  epithelial  healing  process  is  located  in  the  center
of  the  cornea.30 As  only  44  patients  were  included,  in  future
studies  a  larger  size  sample  would  be  recommendable.
Bandage  contact  lenses  also  minimize  corneal  haze.
Edwards  et  al.31 showed  a  minimum  tendency  to  a  high
level  of  corneal  haze  with  Omaﬁlcon  A  compared  with
Lotraﬁlcon  A  (P=.0064).  However,  all  efforts  are  made
to  minimize  the  corneal  haze  intraoperatively,  using  cold
balanced  saline  (BSS)  and  MMC.  Application  of  BSS  in
the  stromal  body  reduces  the  corneal  pain  and  corneal
haze;128 yet,  the  application  of  mitomycin-C  (MMC)  is  more
widely  used.
Although  bandage  contact  lenses  have  various  advan-
tages,  the  presence  of  silicone  may  produce  irritation,
increased  protein  and  lipid  deposits,  and  reduced  wettabil-
ity  because  of  its  hydrophibicity.31 A  plasma  treatment  is
given  to  enhance  the  hydrophilicity  of  Lotraﬁlcon  A surface,
but  this  technique  is  not  completely  effective.31 Bacterial
keratitis  and  subepithelial  inﬁltrates  have  been  described
with  bandage  contact  lenses  after  PRK.17 The  risk  of  infec-
tious  keratitis  of  soft  contact  lenses  ﬁtted  for  approximately
3  days  is  low,  and  antibiotics  are  prescribed  to  further  min-
imize  the  risk.175
Corticosteroids  and  Non-steroidal
Anti-inﬂammatory  Agents  (NSAIDs)  TherapyIt  is  necessary  to  distinguish  between  corneal  haze  that
appears  in  the  ﬁrst  weeks  or  months  after  PRK  and  pathologi-
cal  corneal  haze  that  appears  as  a  result  of  myoﬁbroblasts.71
p
o
t
n161
f  the  corneal  haze  persists  over  time,  it  may  cause  a  corneal
pacity  and  the  thickening  of  the  tissue  that  would  result  in
 regression  of  the  refractive  error,  decreased  visual  acu-
ty  and  irregular  astigmatism.19,34,67,71 Clinically  signiﬁcant
orneal  haze  occurs  in  0.5%--5%  of  the  cases.109 Corneal
aze  that  most  commonly  occurs  after  PRK  is  not  clini-
ally  signiﬁcant,  and  is  not  attributed  to  myoﬁbroblasts.71,121
ccording  to  Wilson,71 in  human  corneas  that  develop  late
orneal  haze  after  PRK,  the  resolution  of  the  opacity  is  slow,
nd  the  restauration  of  the  refractive  correction  is  pro-
uced  between  1  and  3 years  postoperatively.  It  has  been
ostulated  that  the  extinction  of  corneal  haze  can  be  inﬂu-
nced  by  the  disappearance  of  myoﬁbroblasts,  reabsortion
f  abnormal  extracellular  matrix  (ECM)  and  restoration  of
ormal  corneal  structure.71
After  surgery,  a  variety  of  drugs  are  prescribed  to  avoid
orneal  haze,  for  instance,  corticosteroids  --  antiinﬂam-
atories  to  avoid  the  pain  and  inﬂammation-,  plasmin
nhibitors,  growth  factors  or  antimetabolites.13,176 Topical
herapy  after  PRK  prevents  complications  like  keratitis,
nfections  or  corneal  haze.177 The  most  common  treat-
ent  after  PRK  to  avoid  the  corneal  inﬂammation  is
he  application  of  corticosteroids.109,158 Corticosteroids  are
ot  recommended  for  long  periods  because  of  their  side
ffects,  like  intraocular  pressure  (IOP)  rise  and  the  risk
f  cataracts.109,178,179 Javadi  et  al.180 reported  a  rise  in
he  IOP  using  0.1%  betamethasone  at  2  weeks  post-PRK
n  a  minority  of  patients.  Furthermore,  corticosteroids
elay  epithelial  healing.179 When  corneal  haze  appears
--3  months  after  PRK,  the  clinical  observations  conﬁrm
hat  haze  is  ‘‘corticosteroid-responsive’’  in  10%--15%  of
atients.71 Researchers  disagree  about  the  beneﬁt  of  cor-
icosteroids  to  reduce  the  corneal  haze  after  PRK.2,177
ccording  to  Wilson,71 the  topical  administration  of  1%  pred-
isolone  acetate  (Pred  Forte)  quickly  removes  the  corneal
pacity  and  produces  a  change  in  refractive  error.  In  the
emaining  85%  or  90%  of  cases,  the  corticosteroids  do  not
xert  any  change.71 Corticosteroids  could  be  replaced  by
on-steroidal  anti-inﬂammatory  agents  (NSAIDs),  tranilast,
ysteine  or  antioxidants  like  Vitamine  E.109,177 NSAIDs  are
ffective  in  reducing  corneal  pain,  postoperative  photo-
hobia  and  inﬂammation.7,128 The  inﬂammatory  response
s  mediated  by  prostaglandins  synthesized  from  arachidonic
cid  by  cyclooxygenase  1  (COX-1)  or  cyclooxygenase  2  (COX-
).128 The  antiinﬂammatory  and  analgesic  properties  of  the
onsteroidal  anti-inﬂammatory  drugs  (NSAIDs)  are  achieved
y  the  inhibition  of  COXs  activity.7,128
The  use  of  certain  steroidal  and  non-steroidal  anti-
nﬂammatory  drugs  (NSAID)  delay  reepithelialization  and
ncrease  the  risk  of  haze  formation,7 although  the  results
re  still  contradictory.  Vetrugno  et  al.177 proved  that  0.1%
uorometholone  acetate  administered  in  the  ﬁrst  day  after
RK  reduced  corneal  haze  and  myopic  regression,  partic-
larly  in  high  myopic  patients.  NSAIDs  like  diclofenac  and
etorolac  have  shown  reduction  in  the  pain  sensation,7,128
ut  also  a  signiﬁcant  delay  in  corneal  reepithelialization
fter  PRK.181 Nepafenac  (Nevanac;  Alcon  Laboratories  Inc.,
t  Worth,  Tex)  is  a  new  topical  NSAID  with  greater  corneal
ermeability  that  has  been  approved  for  the  treatment
f  inﬂammation  after  surgery.7,181 Jalali  et  al.13 found
hat  0.1%  Nepafenac  did  not  increase  haze  formation,
either  hamper  corneal  epithelial  healing,  but  they  did
1n
r
g
m
s
o
2
(
a
I
s
c
ﬁ
i
C
p
P
d
t
t
f
f
0
i
T
w
s
ﬁ
A
T
h
t
e
k
m
b
t
t
t
a
i
k
l
w
t
t
h
p
t
j
c
d
b
a
I
p

d
t
c
T
p
e
l
P
T
k
i
i
g
t
P
d
f
P
m
T
F
7
r
c
c
t
t
a
a
t
o
a
e
(
a
t
t
a
7
e
l
C
C
T
a
f
r
t
n
t
m
o
a
c
b62  
ot  found  statistically  signiﬁcant  differences  in  corneal
eepithelization  between  nepafenac  and  non-nepafenac
roups  (P=.61).  Caldwell  et  al.,181 in  a  randomized  double-
asked  study,  demonstrated  that  0.1%  nepafenac  was
afe  for  corneal  reepithelialization,  and  reduced  the  post-
perative  pain  at  day  1  (0.76  versus  1.68)  and  day
 (1.26  versus  2.23)  compared  with  the  placebo  group
P<.0005).  Other  NSAIDs  for  corneal  pain  reduction  are
lso  available,  like  Bromfenac,  Flurbiprofen  sodium  and
ndomethacin.7
Despite  the  presence  of  complications  is  low,  non-
teroidal  anti-inﬂammatory  drugs  (NSAIDs)  may  produce
onjunctival  hyperemia,  transient  burning,  stinging,  super-
cial  punctate  keratitis,  epithelial  defects,  subepithelial
nﬁltrates,  corneal  melting  and  perforation.7,17 However,
aldwell  et  al.,181 in  a  randomized  double-masked  study,
roved  that  0.1%  nepafenac  did  not  had  adverse  effects.
ostoperative  oral  analgesics,  like  NSAIDs,  are  able  to  pro-
uce  gastrointestinal,  cardiovascular,  respiratory  and  cen-
ral  nervous  system  complications.17,181 Another  treatment
hat  is  widespread  for  the  inhibition  of  inﬂammation  and
or  treatment  of  dry  eye  is  the  Cyclosporine  A,  with  doses
rom  0.05%  to  2.00%.109 Nien  et  al.109 used  Cyclosporine  A
.05%  and  prednisolone  acetate  0.01%  to  compare  the  effect
n  corneal  haze  prevention  in  rabbit  corneas  following  PRK.
hey  concluded  that  Cyclosporine  A  did  not  have  any  effect,
hereas  prednisolone  acetate  was  effective  in  reducing
hort-term  corneal  haze,  but  did  not  prevent  corneal
brosis.109
lternative  Therapies  for  Corneal  Haze  Prevention
he  use  of  drugs  does  not  completely  suppress  corneal
aze  formation  after  PRK.  Research  has  focused  on  new
herapies  that  could  prevent  corneal  haze,  like  genetic
valuation  of  type  IV  collages  synthesis.33 Lumican  and
eratocan  genes  have  also  been  evaluated  for  manage-
ent  of  subepithelial  persistent  corneal  haze  after  PRK,
ut  without  a  consistent  ﬁnding.182 It  has  been  postulated
hat  vitamin  E,  probulcol  or  heparin  may  inhibit  collagen
ype  IV  synthesis,  but  they  have  not  been  approved  for
opic  use  because  of  their  adverse  effects.33 Vitamin  E
nd  amino  acids  play  an  important  role  in  corneal  reep-
thelialization  and  in  the  prevention  of  corneal  haze  and
eratocyte  apoptosis,  especially  in  high  myopia.9,77 A  pre-
iminary  clinical  trial  concluded  that  oral  supplementation
ith  vitamin  A  and  vitamin  E  accelerated  the  reepitheliza-
ion,  and  reduced  corneal  haze  formation,183 but  it  seems
hat  the  topical  administration  of  vitamin  A  alone  do  not
ave  any  effect.184 Alternative  treatments  to  MMC  that
revent  corneal  haze  formation,  but  produce  less  damage
o  keratocyte  are  bevacizumab  and  rapamycin.185 Subcon-
unctival  injection  of  PRM-151  could  presumably  prevent
orneal  haze,  as  it  inhibits  the  pro-ﬁbrotic  myoﬁbroblast
ifferentation.186 Trichostatin  A,  similarly,  prevents  myoﬁ-
roblast  formation  by  inhibiting  TGF-beta1.187 As  cytokines
nd  growth  factors  control  the  synthesis  of  collagen  type
V,  they  might  be  also  useful  treatments  for  corneal  haze
revention.33 PRK  increases  the  release  of  leukocytes,  TGF-
1,  TNF- and  PDGF-BB  in  human  tears  during  the  ﬁrst
ays  of  wound  healing.14,50 TGF  is  a  cytokine  released  by
e
c
e
dJ.  Tomás-Juan  et  al.
he  lacrimal  gland,  corneal  epithelium  and  conjunctival
ells.179 Three  forms  of  TGF- exist  (TGF-1,  TGF-2 and
GF-3)  and  each  one  is  involved  in  the  wound  healing
rocess  in  a  different  way.  TGF-1 is  increased  in  early
pithelial  healing,  and  exerts  an  inﬂuence  in  the  subepithe-
ial  ﬁbrosis  formation  and  activation  of  keratocytes  after
RK.73 Bühren  et  al.179 proved  that  the  application  of  anti-
GF-  in  felines  reduced  the  differentiation  in  vitro  of
eratocytes  into  myoﬁbroblast,  and  corneal  haze  dimin-
shed.  They  suggested  that  this  reduction  in  differentiation
mproved  optical  quality.  The  combination  of  the  nerve
rowth  factor  (NGF)  and  decosahexanoic  acid  stimulated
he  regeneration  of  basal  epithelial  cells  in  rabbits  after
RK,22 which  is  imperative  for  a  proper  wound  healing.  Med-
uri  et  al.35 studied  the  effect  of  basic  ﬁbroblast  growth
actor  (b-FGF)  in  circumstances  of  delayed  healing  after
RK.9 50  patients  were  enrolled  in  b-FGF  eye  drop  treat-
ent  group  and  50  patients  in  saline  drops  (placebo)  group.
hey  observed  greater  corneal  epithelial  healing  in  the  b-
GF  group  than  in  the  placebo  group  at  4  days  (98%  versus
2%,  respectively)  and  5  days  after  surgery  (100%  versus  92%,
espectively).35
Artiﬁcial  tears  are  the  most  widely  used  solution  for
orneal  lubrication.  However,  they  do  not  have  biological
omponents  that  promote  corneal  regeneration.  In  fact,
hey  contain  stabilizers,  preservatives,  or  other  additives
hat  may  induce  toxic  or  allergic  reactions.51 Blood  derivates
s  plasma  rich  in  growth  factors  are  an  alternative  to
rtiﬁcial  tears,  and  have  not  possibility  of  rejection.51 Ani-
ua  et  al.51 proved  that  plasma  rich  in  growth  factors
btained  from  patient’s  blood  enhanced  corneal  healing,
nd  reduced  the  formation  of  corneal  haze.  The  differ-
nce  between  the  plasma  rich  in  growth  factors  group
PRGF-Endoret  treatment)  and  control  group  was  negligible
t  day  3.  They  attributed  it  to  the  increase  of  prolifera-
ive  cells  (Ki-67  þ)  in  the  control  group.  They  suggested
hat  the  increase  in  proliferative  cells  could  be  associ-
ted  with  epithelial  hyperplasia  observed  at  day  3  and
 after  PRK  in  control  group.51 They  also  found  that  the
pithelium  of  the  PRGF-Endoret  group  was  formed  by  5--6
ayers.51
orneal  Nerve  Regeneration  and  Neuropathic
orneal  Pain  Management
he  regeneration  of  the  corneal  nerves  after  PRK  is  associ-
ted  with  the  improvement  of  cellular  integrity.22 To  date,
ew  therapeutic  treatments  have  been  developed  for  nerve
egeneration.  Javaloy  et  al.188 investigated  the  beneﬁts  of
opical  platelet-rich  plasma,  but  subbasal  nerve  density  did
ot  improve  after  3  months  of  treatment  compared  to  con-
rols  (P=.66).  Studies  in  animal  models  have  demonstrated
ore  encouraging  results.  Esquenazi  et  al.22 studied  the
utcomes  of  the  combination  of  nerve  growth  factor  (NGF)
nd  docosahexaenoic  acid  (DHA)  in  rabbits  in  promoting
orneal  nerve  regeneration.  They  observed  that  this  com-
ination  increased  corneal  nerve  regeneration,  as  well  as
pithelial  proliferation  and  decreased  rose  bengal  staining
ompared  to  the  application  of  NGF  or  DHA  alone.  Cortina
t  al.189 showed  similar  results  with  pigment  epithelial-
erived  factor  (PEDF)  plus  docosahexaenoic  acid  (DHA).
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Directions for Future Research
This  review  clearly  states  that  corneal  regeneration
after  PRK  is  not  completely  understood.  The  ongoing
research  in  new  drugs  development,  more  efﬁcient  sur-
gical  techniques,  and  new  imaging  technologies  are
trying  to  answer  some  of  the  unresolved  questions.
Still,  future  research  should  be  oriented  to  elucidate
the  following  aspects:
•  The  long-term  effects  of  keratocyte  death  and  MMC
application.
•  Although  corneal  haze  has  been  correlated  to  several
factors,  its  origin  is  still  unknown.
•  The  beneﬁcial  role  of  corticosteroid  administration
in  corneal  haze  prevention.
•  The  causal  factors  of  myopic  regression.
•  More  studies  using  non-contact  gas  esthesiometer
will  help  to  better  assess  the  time  course  of  corneal
sensitivity  recovery.
A
A
f
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Moreover,  this  combination  proved  to  enhance  corneal  sen-
sitivity.  Recent  evidences  suggest  that  peripheral  nervous
system  regeneration  and  inﬂammatory  processes  share  com-
mon  pathways,  and  some  degree  of  inﬂammation  is  required
for  neuroregeneration.190 Therefore,  cyclosporine  A  and  cor-
ticosteroid  treatments  could  interfere  in  a  proper  nervous
recovery.
When  corneal  nerve  regeneration  process  fails,  corneal
neuropathic  pain  might  take  place.  The  up-  and  down-
regulation  of  ion  channels  in  axotomized  nerves  can  change
the  excitability  of  ﬁbers,191 and  produce  spontaneous  dis-
charges  and  altered  sensibility  to  exogenous  stimuli.192 This
would  result  in  corneal  pain  non-treatable  with  aforemen-
tioned  drugs.  Anticonvulsants,  opiates  and  topical  local
anesthetics  can  manage  corneal  neuropathic  pain.  The
anticonvulsant  Gabapentin  (Neurontin)  is  an  analog  of
gamma-aminobutyric  acid  (GABA),193 and  its  reliability  in
treating  corneal  pain  is  conﬂicting,  mainly  because  of  a
lack  of  studies.7 Lichtinger  et  al.193 compared  in  a  prospec-
tive  randomized,  double-blind,  placebo-controlled  study  the
efﬁcacy  of  Gabapentin  in  the  reduction  of  the  corneal
pain.  They  administrated  gabapentin  capsules  (300  mg)  in
20  patients  and  additional  20  patients  received  identi-
cal  placebo  capsules.  They  demonstrated  that  gabapentin
reduced  corneal  pain  during  the  ﬁrst  24  h  (P=.003),  at  post-
operative  day  1  (P=.002),  between  24  and  48  h  (P=.024),
at  postoperative  day  2  (P=.018)  and  between  48  and  72  h
(P=.001).  Faktorovich  et  al.17 trying  to  prove  the  efﬁ-
cacy  of  topical  opioid  in  the  treatment  of  pain,  concluded
in  a  double-blind  randomized  prospective  study  that  the
administration  of  0.5%  morphine  drops  was  an  effective
and  safe  method  to  control  of  post-PRK  pain,  and  did  not
hamper  epithelial  healing  or  refractive  outcomes.  Topical
local  anesthetics  include  tetracaine,  proparacaine,  lido-
caine  and  bupivacaine  can  be  also  used.  Topical  tetracaine
has  been  documented  to  be  successful  in  pain  control
management  and  does  not  produce  delayed  corneal  heal-
ing  times.7,39 However,  it  produces  keratocyte  toxicity  and
keratitis.7,17,39 Topical  anesthetics  should  be  used  cautiously
and  for  short-term  treatments.  Antidepressants  are  pre-
scribed  for  neuropathic  pain  management  elsewhere  in  the
body.  To  date,  no  study  has  been  published  evaluating
the  effect  of  antidepressants  for  treating  post-PRK  corneal
pain.
Conclusions
Photorefractive  keratectomy  disrupts  corneal  structure
affecting  epithelium,  Bowman’s  membrane,  and  ante-
rior  stroma.  Corneal  nerves  are  severed,  which  alters
corneal  integrity  and  function  temporarily.  The  subse-
quent  corneal  wound  healing  is  a  complex  process  that
is  regulated  by  a  variety  of  factors.  A  balance  of  pep-
tides  will  determine  the  ﬁnal  outcome,  and  the  presence
of  postoperative  complications.  Corneal  wound  healing
process  can  be  managed  with  several  drugs  to  enhance
regeneration  and  prevent  corneal  haze  and  pain  after
PRK.  Further  research  in  this  ﬁeld  is  required  to  com-
pletely  understand  post-PRK  corneal  regeneration  in  order
to  prevent  complications,  and  provide  outstanding  visual
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